What is the catalog number for Vitamin D Receptor/VDR Rabbit Polyclonal Antibody?

The catalog number for Vitamin D Receptor/VDR Rabbit Polyclonal Antibody is orb259633.

What sizes are available for Vitamin D Receptor/VDR Rabbit Polyclonal Antibody?

Vitamin D Receptor/VDR Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Vitamin D Receptor/VDR Rabbit Polyclonal Antibody in stock?

Vitamin D Receptor/VDR Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Vitamin D Receptor/VDR Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

Vitamin D3 receptor; VDR; 1, 25-dihydroxyvitamin D3 receptor; Nuclear receptor subfamily 1 group I member 1; VDR; NR1I1

UniProt

P11473

Reactivity

Human, Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence at the C-terminus of human VDR, different from the related mouse and rat sequences by one amino acid.

Target

Vitamin D3 receptor

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Epigenetics & Chromatin, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Human, Mouse, Rat Western blot, 0.1-0.5μg/ml, Human, Rat

Form

Lyophilized

Molecular Weight

48 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.